A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.
Lupin has FDA approval for Armlupeg 6mg/0.6ml injection in a single-dose prefilled syringe, for subcutaneous use, as a biosimilar to Neulasta.
West Pharmaceutical Services is the winner of the Product Launches Award for Prefillable Syringe Systems in the 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback